BioSpace News Archive

Theranica today announced the appointment of two senior executives amid growing demand for the company’s prescription migraine treatment device Nerivio®.

BioMed Realty announced today they have been awarded a Deal of the Year Award for their Zymergen lease at Emeryville Center of Innovation, presented by the San Francisco Business Times. Additionally, BioMed Realty’s President and CEO Tim Schoen has been recognized as the Dealmaker of the Year . This press release features multimedia. View the full r

Avellino announced the rollout of the new A.C.T.S. Program (Active Coronavirus Testing & Safety) designed to help ophthalmology and other elective surgery and procedure-oriented practices safely reopen and resume care while protecting patients and staff from COVID-19 virus transmission. Avellino Group Chairman Gene Lee said, “As states ease their shelte

Phosphorus, a leading genomics firm headquartered in New York City and New Jersey, announced today that it has created two COVID-19 tests that are currently available for home delivery in the NYC metropolitan area through its in-home provider testing service.

Diaceutics names its platform ‘ DXRX - The Diagnostic Network™’ It will be launched in Q4, 2020 DXRX puts 2500+ laboratories at the center of a precision medicine network DXRX is world’s first diagnostic network enabling industry-wide collaboration needed for precision medicines to fulfil their promise DXRX will unlock power of world’s largest real-world testing data repository for network of industry partnerships Company

Abcore, Inc., a leader in contract research and development of single domain antibodies announced a panel of functional therapeutic candidates they have discovered and tested for the treatment of Coronavirus Disease 2019 (COVID-19).

Cabaletta Bio, Inc. (Nasdaq: CABA), today announced that in vivo data demonstrating specific engagement and elimination of anti-muscle-specific tyrosine kinase (MuSK) antibody-expressing target cells by Chimeric AutoAntibody Receptor (CAAR) T cells was presented at the American Academy of Neurology (AAN) 2020 Science Highlights Virtual Platform

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop treatments for patients with severe diseases including solid tumors, hematologic cancers and autoimmune disease, today reported the grant of inducement awards to Jakob Dupont, its Executive Vice President, Global Head of Research & Development.

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced financial results for the first quarter ended March 31, 2020 and provided a business update.

Ortho’s IgG test demonstrates 100% specificity and can be used to support decisions for getting people back to work and can support convalescent plasma screening